Study of a Therapy Without Drugs, Supplementary to an Usual Treatment for the Pains Caused by Removing the Redon’s Drain From a 7 to 17 Years Old Child in Pediatric Surgery.

Overview

The 3rd governmental plan of fighting against the pain favored the development and the evaluation of the efficiency of the non pharmacological methods. Its results always showes a lack of knowledge of these methods and the utility to pursue the researches. In the department of pediatric surgery of the university hospital of Limoges, the relaxing-touch is one of these methods which is more and more used. The healthcare staff noticed the beneficial effects of such an empirical method in terms of comfort and quality of life for the children. In 2011, a pilot study led in this department showed that, in spite of the usual treatment, the removal of the Redon's drain remains painful for 25 % of the children (score on the pain scale > or = 4). This result convinced the medical team to write a protocol of research from the following hypothesis: the implementation of a protocol of the Redon's drain removal associated to the relaxing touch and usual treatment could lead to a decrease of the acute pain for a 7 to 17 years old child.

Full Title of Study: “Study of a Therapy Without Drugs, Supplementary to an Usual Treatment for the Pains Caused by Removing the Redon’s Drain From a 7 to 17 Years Old Child in Pediatric Surgery.”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Supportive Care
    • Masking: None (Open Label)
  • Study Primary Completion Date: November 2018

Interventions

  • Other: Relaxing-touch method

Arms, Groups and Cohorts

  • Experimental: Relaxing-touch method
  • No Intervention: Usual care

Clinical Trial Outcome Measures

Primary Measures

  • To compare the score of pain, just after the removal of the Redon’s drain
    • Time Frame: 5 minutes
    • The score of pain, just after the removal of the Redon’s drain, constitutes the main end point. It will be collected by the score of the EVA (scores from 0 to 10)

Secondary Measures

  • To compare, for 2 groups, the Score of pain: EVA scale (score 0-10).
    • Time Frame: 5 minutes
    • Score of pain: EVA scale (score 0-10). The 2 groups average EVA level will be compared.
  • Percentage of children with a pain rating ≥ 4
    • Time Frame: 5 minutes
    • The Percentage of children with a pain rating ≥ 4 will be compared between the two groups in children aged 7 to 11 and 12 to 17 years old
  • To compare, for 2 groups, the average level of EVA-anxiety scores
    • Time Frame: 5 minutes
    • Comparison of the average level of “EVA-anxiety” scores in the two groups of children before treatment
  • Proportion of children with a pain level ≥ 4 during removal of the drain
    • Time Frame: 5 minutes
    • the proportion of children with a pain level ≥ 4 during removal of the drain in the group of children who underwent an orthopedic procedure; a visceral act; an act thoracic; an act for gynecomastia; an act for burn treatment by prosthesis expansion;

Participating in This Clinical Trial

Inclusion Criteria

  • Children > or = 7 and < 18 years old – Hospitalization for surgery having required the settle of a Redon's drain during surgery. – The presence of at least one of the legal representatives with the child during the care. – The consent of at least one of the legal representatives and agreement of the child for the relaxing-touch method. – The affiliation of one of the legal guardian to the social security. Exclusion Criteria:

  • Children with an intellectual deficiency preventing the use of the scale EVA from the pain. – Children having already had one or several removal of the Redon's drain: the negative memory of the pain for a similar act could falsify the score of pain – Children refusing the usual care of the pain in the department by the MEOPA.

Gender Eligibility: All

Minimum Age: 7 Years

Maximum Age: 17 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • University Hospital, Limoges
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Laurent FOURCADE, MD, Principal Investigator, University Hospital of Limoges

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.